This company has been acquired
Pardes Biosciences Management
Management Kriterienprüfungen 1/4
Pardes Biosciences' CEO is Tom Wiggans, appointed in Mar 2022, has a tenure of 1.5 years. total yearly compensation is $5.26M, comprised of 9.9% salary and 90.1% bonuses, including company stock and options. directly owns 0.082% of the company’s shares, worth $107.99K. The average tenure of the management team and the board of directors is 2.7 years and 2.4 years respectively.
Wichtige Informationen
Tom Wiggans
Geschäftsführender
US$5.3m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 9.9% |
| Amtszeit als Geschäftsführer | 1.5yrs |
| Eigentum des Geschäftsführers | 0.08% |
| Durchschnittliche Amtszeit des Managements | 2.7yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 2.4yrs |
Jüngste Management Updates
Recent updates
We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate
Jul 18
Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation
Jan 20We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully
Oct 01Pardes begins phase 2 trial of oral drug PBI-0451 for COVID-19
Sep 13Pardes Biosciences GAAP EPS of -$0.48
Aug 15Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans
Jun 14Pardes Biosciences: Advancing A Viral Protease Inhibitor Platform
Jan 21Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$76m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$5m | US$521k | -US$97m |
Vergütung im Vergleich zum Markt: Tom's total compensation ($USD5.26M) is above average for companies of similar size in the US market ($USD758.93K).
Entschädigung vs. Einkommen: Insufficient data to compare Tom's compensation with company performance.
Geschäftsführer
Tom Wiggans (71 yo)
1.5yrs
Amtszeit
US$5,255,958
Vergütung
Mr. Thomas G. Wiggans, also known as Tom, serves as Independent Director at CymaBay Therapeutics, Inc. since April 2021. He serves as an Executive Chairman of Follica, Inc. since January 2021. He serves as...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Chairman of the Board | 1.5yrs | US$5.26m | 0.082% $ 108.0k | |
| Founder & Director | no data | US$3.52m | 9.35% $ 12.3m | |
| Chief Financial Officer | 2.7yrs | US$1.82m | 0.52% $ 684.2k | |
| General Counsel & Corporate Secretary | 2.7yrs | keine Daten | 0.35% $ 456.1k |
2.7yrs
Durchschnittliche Betriebszugehörigkeit
56.5yo
Durchschnittliches Alter
Erfahrenes Management: PRDS's management team is considered experienced (2.7 years average tenure).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Chairman of the Board | 1.5yrs | US$5.26m | 0.082% $ 108.0k | |
| Founder & Director | 3.6yrs | US$3.52m | 9.35% $ 12.3m | |
| Director | 2.7yrs | US$110.69k | keine Daten | |
| Independent Director | 2.7yrs | US$170.69k | 0.12% $ 152.0k | |
| Independent Director & Member of Scientific Advisory Board | 3.1yrs | US$153.69k | 0.12% $ 152.0k | |
| Independent Director | 2.7yrs | US$163.19k | 2.25% $ 2.9m | |
| Independent Director | less than a year | US$147.00k | 0% $ 0 | |
| Independent Director | 2.2yrs | US$161.19k | 0% $ 0 | |
| Lead Independent Director | less than a year | US$146.94k | 0% $ 0 | |
| Independent Director | 2.2yrs | US$153.69k | 0% $ 0 | |
| Member of Commercial Advisory Board | no data | keine Daten | keine Daten |
2.4yrs
Durchschnittliche Betriebszugehörigkeit
62.5yo
Durchschnittliches Alter
Erfahrener Vorstand: PRDS's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.